111In-labeled immunoconjugates (ICs) bispecific for the epidermal growth factor receptor (EGFR) and cyclin-dependent kinase inhibitor, p27Kip1.

Podobne knjige/članki

• Biodistribution and nuclear import of 111In-labeled HIV-1 tat peptide immunoconjugates after intravenous or intratumoural injection in tumour-bearing mice
  od: Cornelissen, B, et al.
  Izdano: (2006)
• Kinetics of internalization and nuclear import and efflux of 111In-and 123I-labeled HIV-1 tat-peptide immunoconjugates (IC's) in BT-474 human breast cancer cells
  od: Cornelissen, B, et al.
  Izdano: (2006)
• In vivo monitoring of intranuclear p27(kip1) protein expression in breast cancer cells during trastuzumab (Herceptin) therapy.
  od: Cornelissen, B, et al.
  Izdano: (2009)
• Cellular penetration and nuclear importation properties of 111In-labeled and 123I-labeled HIV-1 tat peptide immunoconjugates in BT-474 human breast cancer cells.
  od: Cornelissen, B, et al.
  Izdano: (2007)
• Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo.
  od: Zhang, W, et al.
  Izdano: (2005)